banner

Stock Chart Videos back to homepage

Aeterna Zentaris Stock Chart Analysis Video Aeterna Zentaris Stock Chart Analysis Video(0)

Three straight days of closing ahead has the AEterna Zentaris chart on watch for continued upward pressure. Shares rose 8.5 percent on Tuesday to close near the high of the day on increased volume, which is a bullish sign as the stock nears resistance. Shares traded as low as $1.75 last week, but have recovered to close on Tuesday at $2.16 on Read More

Nautilus Stock Chart Analysis Video Nautilus Stock Chart Analysis Video(0)

Although the chart for Nautilus Inc. (NYSE: NLS) fell sharply in July, the stock has still posted solid gains for 2012 and is back on the rise. Resistance is ahead around $3.00, but the chart is showing bullish signs of trend and momentum, indicating that if the resistance is broken, a run at the 52-week high could happen.

Headquartered in Vancouver, Washington, Nautilus, Inc. is a global fitness products company providing innovative, quality solutions to help people achieve a healthy lifestyle. With a brand portfolio including Nautilus®, Bowflex®, TreadClimber®, Schwinn®, Schwinn FitnessTM, Universal® and CoreBody Reformer™, Nautilus markets innovative fitness products through Direct and Retail channels.


Nautilus Group (NLS) Stock Quote and News:







Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

PositiveID Stock Chart Analysis Video PositiveID Stock Chart Analysis Video(0)

The PositiveID (OTCBB: PSID) stock chart made a new 52-week low yesterday before buying pressure pulled the stock price up to close the day with a hammer/doji candle. A possible reversal candle, the chart is holding support firmly at 3 cents with resistance not coming into play until 4 cents. A long-term positive divergence between the MACD and the PPS has the chart on radar for an overall trend shift. Read More

CrowdGather Stock Chart Analysis Video CrowdGather Stock Chart Analysis Video(0)

The CrowdGather (OTCBB: CRWG) chart keeps producing 25 percent bounces off a solid support at 20 cents back up to a resistance at 25 cents. The pps continues to hold over the 200 day simple moving average and is looking towards the 50 dma at 27 cents. The indicators look to be trying to reverse course as the Relative Strength Index is now pushing through the 50 mark, indicating that momentum is entering a bullish mode. Static resistance is ahead at 30 cents. If tested, the climb off support could be indicating a reversal Read More

Anthera Pharmaceuticals Stock Chart Analysis Video Anthera Pharmaceuticals Stock Chart Analysis Video(0)

A look at Anthera Pharmaceuticals’ (NASDAQ: ANTH) 15-minute charts, combined with the daily charts, shows that the stock could be aligning for a “dead cat bounce.” Technical traders will be looking for a new support level to be established and any upward movement to meet resistance near $0.80, where the stock still has a short-term, open gap that is unfilled presently.

The stock has languished Read More

RXI Pharmaceuticals Stock Chart Analysis Video RXI Pharmaceuticals Stock Chart Analysis Video(0)

Even though RXI Pharmaceuticals Corp. (OTCBB: RXII) has only been trading for less than two months, the technicals show that a base has formed and that there is potential for a move in the near term as the moving averages have converged and the bollinger bands are tightening. Technical traders will be watching for an increase in volume to hold support at 8 cents and for pressure to try and take out resistance Read More

Medical Marijuana Stock Chart Analysis Video Medical Marijuana Stock Chart Analysis Video(0)

After a pullback from a recent run that saw the price per share more than double, the Medical Marijuana Inc. (Pink Sheets: MJNA) stock chart is on watch for a bounce. Support is established at 3.5 and 4 cents with resistance in place at 5 and 6 cents. Read More

LIG Assets Stock Chart Analysis Video LIG Assets Stock Chart Analysis Video(0)

The LIGA stock chart is forming a double bottom pattern with solid support at 4 cents. The most recent move off of the support resulted in a move to nearly a dime, representing a climb of 140 percent. Volume increased today which will have technical traders watching for another move off support and a run at completion of the pattern.

LIG Assets, Inc., based in Dallas, TX, is a multi-faceted worldwide investment company that focuses on real estate, technology, and other sectors of the economy. LIG Assets is a proactive company that is committed to providing opportunities in all structures of the economy and are always welcoming new opportunities.



LIG Assets (LIGA) Stock Quote and News:







Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated one thousand dollars by an independent third party for the creation and dissemination of a video chart analysis on LIG Assets, Inc. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

Bon-Ton Stores Stock Chart Analysis Video Bon-Ton Stores Stock Chart Analysis Video(0)

With a solid support level at $3.50, Bon-Ton Stores Inc. (NASDAQ: BONT) made a small move yesterday to bounce off that point. The indicators are set for a rise with a resistance point 25 percent away, which should have technical traders watching closely for bullish pressure and the support to continue to hold on any pullback. Read More

ALR Technologies Stock Chart Analysis Video ALR Technologies Stock Chart Analysis Video(0)

A look at the three-year weekly chart for ALR Technologies (OTCBB: ALRT) shows a baseline pattern and support at 6 cents with additional support at 7 cents. Higher lows have been progressively made over the three years with a top-end resistance at 24 cents. The chart is just above Read More



Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.